信达生物(01801)授出1.5万份购股权及14.82万股受限制股份

Group 1 - Company announced the grant of 15,000 stock options to 3 grantees under the 2024 share plan [1] - Additionally, the company granted 148,200 restricted shares to 29 grantees, pending acceptance by the grantees [1]